pargyline has been researched along with neuropeptide y in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TK; Cheng, JT; Niu, CS | 2 |
2 other study(ies) available for pargyline and neuropeptide y
| Article | Year |
|---|---|
Changes of neuropeptide Y messenger RNA and peptide by drugs influencing endogenous norepinephrine content in cerebrocortex of the rat.
Topics: Animals; Antihypertensive Agents; Blotting, Northern; Cerebral Cortex; Enkephalin, Leucine; Fusaric Acid; Hypotension; Male; Neuropeptide Y; Norepinephrine; Pargyline; Radioimmunoassay; Rats; Rats, Wistar; RNA, Messenger | 1996 |
Activation of alpha 1-adrenoceptors to lower cerebrocortical neuropeptide Y (NPY)-like immunoreactivity in rats receiving pargyline treatment.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antibody Specificity; Cerebral Cortex; Dopamine Antagonists; Haloperidol; Injections, Intraventricular; Male; Methoxamine; Monoamine Oxidase Inhibitors; Neuropeptide Y; Pargyline; Prazosin; Propranolol; Radioimmunoassay; Rats; Rats, Wistar | 1996 |